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Abstract
Introduction: Leydig cells tumors of the testis are uncommon, representing between 1 and 3% of the
testicular tumors and for which the natural history and therapy are debated between radical orchitectomy
and organ-sparing surgery.
Subjects  and  methods: We report three new cases of Leydig cells tumors, treated in our department and we
discuss the clinical, diagnostic and therapeutic aspects of this uncommon tumor.
Results: The mean patient age was 29 years (23–37 years). Medical referral was for a testicular pain in
two and gynecomastia in one case. All patients were treated surgically, through an inguinal incision and
the procedure included clamping of the spermatic cord. During surgery, frozen section were analyzed in
two cases and the tumor enucleation with organ-sparing surgery was performed. The other patient had an
unilateral orchidectomy and controlateral tumorectomy. The mean follow-up was 40 months with no local
recurrence.
Conclusion: Patients diagnosed with Leydig cells tumors have a good prognosis; this study shows the safety
of conservative surgery treatment, provided it is subsequently followed by close surveillance, as it preserves
umor
gical
C-NDmaximum fertility, and these t
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ntroduction
eydig cell tumor (LCT) is the most frequent interstitial neoplasms
f the testis [1], accounting for 0.8–3% of all testicular tumors [2]
nd 4–9% of testis tumors in prepubertal males [3]. The recent
urgical approach to treat these tumors is conservative [4].
 license.ere we report three new cases of Leydig cell tumors treated with
rgan-sparing surgery and we discuss the clinical, diagnostic and
ollow-up of this uncommon tumor.
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Case  reports
Since 2005, we have diagnosed three new cases of Leydig cell
tumor of the testis, in patients A, B and C (aged 23, 28 and 37
years, respectively). Patient A with history of precocious puberty
due to congenital adrenal hyperplasia was referred for bilateral tes-
ticular pain. Patient B consulted for mild left testicular pain and
swelling of several months’ duration. Patient C presented with a one-
year history of symptomatic left gynecomastia, which on ultrasound
examination had the appearance of simple gynecomastia (confirmed
by fine needle aspiration). Physical examination of the external gen-
italia revealed a mildly enlarged and sensitive bilateral testes in
patient A, and left higher testicular pole in patients B and C. In
all patients, testicular ultrasound showed a homogeneous, hypoe-
chogenic nodule within the testis and increased vascular perfusion
(Figs. 1 and 2). Laboratory findings of AFP, -hCG were within
normal ranges, except for patient C who has increased level. Chest
X-ray was normal in all cases.
Patient A was treated by unilateral orchidectomy and controlateral
tumorectomy. Patients B and C underwent tumor enucleation and
frozen sections were analyzed during surgery (Fig. 3). There were
no complications during or after surgery.In all patients the diagnosis of LCT was confirmed by the defini-
tive pathological report. Histopathological examination revealed
Figure  1  Ultrasound showed a homogeneous, hypoechogenic nodule
within the left testis.
Figure  2  Doppler sonography showing high vascularity of Leydig
cell tumor with a prominent peripheral blood flow.
w
T
f
d
D
L
[
e
t
p
A
s
H
i
i
F
digure  3  Macroscopic appearance of testicular Leydig cell tumor is
rown and well demarcated mass.
ells which had a round nucleus, often with a moderate sized
entral nucleolus, exhibiting moderate variation in size and an
bundant eosinophilic cytoplasm. Numerous rod-shaped intracyto-
lasmic crystals, Reinke’s crystalloids, were observed.
n exceptional mitotic figure was present. Necrosis and hemorrhage
as not seen (Fig. 4). Inhibin-alpha and vimentine were positive.
he mean follow-up was 40 months (10–56 months). No patient died
rom the disease during the follow-up and none developed local nor
istant recurrence.
iscussion
eydig cell tumors of the testis are rare and benign in most cases
5]. Symptoms at presentation are rarely suspicious for the pres-
nce of LCT of the testis. The presenting features are enlarged
estis, gynecomastia and sexual dysfunction. In prepubertal cases,
resenting manifestations are usually those of isosexual precocity.
symptomatic tumors may be detected incidentally in testicular
onography [6].ormonal activity is found in 20% of the cases, including
ncreased estradiol and decreased testosterone serum levels, lead-
ng to adult feminization and children masculinization, respectively.
igure  4  Histologic section shows cells with round nucleus and abun-
ant eosinophilic cystoplasm.
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Table  1  Some studies reported in the literature and their follow-up.
First author Number of cases Mean age (years) Recurrence Follow-up (months)
Carmignani (2007) [5] 22 35 (5–61) No 41 (1–230)
Giannarini (2007) [9] 17 41.6 (28–55) No 91 (12–192)
Suardi (2009) [8] 29 – No 4.6 (0.6–16.2)
Loeser (2009) [7] 8 34 (18–49) One metachronous in
the spermatic cord
41 (1–86)
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[Bozzini (2013) [4] 22 35 (5–6
Our study 3 29 (23–
he endocrinologic manifestation may precede the palpable testis
umors [6].
adiologically, LCT of the testis typically has a homogeneous
ypoechoic sonographic appearance, with peripheral hypervascu-
arization.
o the best of our knowledge, testis sparing surgery was per-
ormed for Leydig cell tumors with good results [4]. It allows the
reservation of testicular parenchyma and avoids the psychosocial
onsequences related to orchiectomy [5]. We opted to this conserva-
ive approach, as several studies reported in Table 1 and no patient
as developed a local or distant recurrence.
he prognosis for benign Leydig cell tumors is excellent. The
linical and hormonal manifestations remit after orchidectomy or
umorectomy in 90% of the cases. But, the persistence of viril-
zing and feminizing features is not necessarily an indication of
alignancy and these features may be to some extent irreversible
6].
onclusion
lthough many teams prefer total orchidectomy because of the
iagnostic difficulty associated with malignant forms, simple
umorectomy should become the first-line treatment, provided it
s subsequently followed by close surveillance, as it preserves max-
mum fertility, and these tumors usually have a favorable prognosis.
[No 180 (77–290)
No 40 (10–56)
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